Expression of Semaphorin 3E Is Suppressed in Severe Asthma

Publication date: Available online 12 May 2017
Source:Journal of Allergy and Clinical Immunology
Author(s): Hesam Movassagh, Lianyu Shan, Jamila Chakir, John F. McConville, Andrew J. Halayko, Latifa Koussih, Abdelilah S. Gounni
The level of a previously unknown mediator, Semaphorin 3E, is diminished in the airways of severe allergic asthmatic patients. This study suggests a potential role of Semaphorin3E in the pathogenesis of asthma severity.



http://ift.tt/2puGVLY